Target
SOS2
1 abstract
Abstract
Artificial intelligence–based biomarkers of response to immunotherapy in patients with non–small-cell lung cancer considering previous lines of treatment.Org: ArianaPharma, Centre Leon Berard, Centre Léon Bérard, AP-HP at Saint-Louis Hospital, University Claude Bernard Lyon 1,